Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Latent TB Testing Market (2023 Edition)” which provides a complete analysis of the Global Latent TB Testing industry in terms of market segmentation By Test Type (Tuberculin Skin Test -TST, Interferon Gamma Released Assay -IGRA), By End User (Diagnostic Laboratories, Hospitals and Clinics, Academic and Research Institute), By Region (Americas, Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, China, Japan, India, South Korea, Australia). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Latent TB Testing Market is expected to generate USD 3.93 Billion by the end of 2029, up from USD 1.8 Billion in 2022. A favourable growth element for the global Latent TB Testing market is propelled by government initiatives and policies, raising awareness and education, and technological advancements in testing methods. During the forecast period, 2024-2029, Global Latent TB Testing is expected to expand at a CAGR of 12%. The prevalence of TB, especially in high-burden regions, drives the need for effective latent TB testing. As TB remains a global health concern, early detection and management of latent infections become critical for disease control.

According to the National Library of Medicine, “one-third” of the world's population, or roughly 2.3 billion people, have LTBI. The WHO estimates that approximately 2 billion people, or more than one-third of the global total, are TB carriers. A high prevalence of latent TB indicates a larger pool of individuals at risk of developing active TB. Latent TB testing becomes essential for identifying those with latent infections, allowing for early intervention and preventive measures.

Technological advancements contribute to the improvement of latent TB testing methods, making them more reliable, convenient, and suitable for diverse healthcare settings. Continued research and innovation in the field are expected to further enhance the accuracy and accessibility of latent TB testing in the future.

The development of next-generation interferon-gamma release assays (IGRAs), such as the QuantiFERON-TB Gold Plus, represents an improvement over earlier versions. These assays offer enhanced sensitivity and specificity in detecting latent TB infections, reducing the likelihood of false-positive results.

Quality assurance and standardization in diagnostic laboratories are gaining prominence. Adherence to international quality standards and the establishment of standardized testing protocols are essential for ensuring the reliability and comparability of latent TB test results. Laboratories are focusing on maintaining high-quality testing procedures. Ongoing R&D efforts lead to the development of improved testing technologies, such as next-generation assays and advanced molecular diagnostic methods. These technologies often offer enhanced sensitivity, specificity, and faster turnaround times, improving the overall efficiency of latent TB testing.



Scope of the Report:

• The report analyses the Latent TB Testing Market by Value (USD Million).

• The report presents the analysis of the Latent TB Testing Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Latent TB Testing Market by Test Type (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)).

• The report analyses the Latent TB Testing Market by End User (Diagnostic Laboratories, Hospitals and Clinics, Academic and Research Institute).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.

• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include QIAGEN, Sanofi, Abbott Laboratories, Serum Institute of India, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, PerkinElmer Inc., BioMerieux, Becton Dickinson and Co, LIONEX GmbH.

ページTOPに戻る

Table of Contents

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Strategic Recommendations

2.1 Amplify the incorporation of technological advancement in diagnostic laboratories

2.2 Increase the R&D spending to improve the efficacy of testing rates



3. Global Latent TB Testing Market: Historic and Forecast (2019-2029)

3.1 Impact Analysis of Macro Economic Factors on Global Latent TB Testing Market

3.2 Epidemiology: Global Latent TB Prevalence

3.3 Epidemiology: Global Tuberculosis Prevalence

3.4 Epidemiology: Global Tuberculosis Incidence

3.5 Global Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

3.6 Degree of Impact of COVID-19 on Latent TB Testing Market

3.7 Global Latent TB Testing Market Segmentation: By Test Type

3.7.1 Global Latent TB Testing Market, By Test Type Overview

3.7.2 Global Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)

3.7.3 Global Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)

3.8 Global Latent TB Testing Market Segmentation: By End User

3.8.1 Global Latent TB Testing Market, By End User Overview

3.8.2 Global Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)

3.8.3 Global Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)

3.8.4 Global Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)



4. Global Latent TB Testing Market, Regional Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Latent TB Testing Market: Historic and Forecast (2019-2029)

5.1 Americas Latent TB Testing Market: Snapshot

5.2 Americas Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.3 Americas Latent TB Testing Market: Key Factors

5.4 Americas Latent TB Testing Market: Segment Analysis

5.5 Americas Latent TB Testing Market Segmentation: By Test Type

5.5.1 Americas Latent TB Testing Market, By Test Type Overview

5.5.2 Americas Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)

5.5.3 Americas Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)

5.6 Americas Latent TB Testing Market Segmentation: By End User

5.6.1 Americas Latent TB Testing Market, By End User Overview

5.6.2 Americas Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)

5.6.3 Americas Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)

5.6.4 Americas Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)

5.7 Americas Latent TB Testing Market Segmentation: By Country

5.7.1 Americas Latent TB Testing Market, By Country Overview

5.7.2 United States Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.7.2.1 United States Latent TB Testing Market, By Test Type

5.7.2.2 United States Latent TB Testing Market, By End User

5.7.3 Canada Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.7.3.1 Canada Latent TB Testing Market, By Test Type

5.7.3.2 Canada Latent TB Testing Market, By End User

5.7.4 Rest of Americas Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.7.4.1 Rest of Americas Latent TB Testing Market, By Test Type

5.7.4.2 Rest of Americas Latent TB Testing Market, By End User



6. Europe Latent TB Testing Market: Historic and Forecast (2019-2029)

6.1 Europe Latent TB Testing Market: Snapshot

6.2 Europe Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.3 Europe Latent TB Testing Market: Key Factors

6.4 Europe Latent TB Testing Market: Segment Analysis

6.5 Europe Latent TB Testing Market Segmentation: By Test Type

6.5.1 Europe Latent TB Testing Market, By Test Type Overview

6.5.2 Europe Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)

6.5.3 Europe Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Latent TB Testing Market Segmentation: By End User

6.6.1 Europe Latent TB Testing Market, By End User Overview

6.6.2 Europe Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)

6.6.4 Europe Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Latent TB Testing Market Segmentation: By Country

6.7.1 Europe Latent TB Testing Market, By Country Overview

6.7.2 Germany Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.7.2.1 Germany Latent TB Testing Market, By Test Type

6.7.2.2 Germany Latent TB Testing Market, By End User

6.7.3 United Kingdom Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.7.3.1 United Kingdom Latent TB Testing Market, By Test Type

6.7.3.2 United Kingdom Latent TB Testing Market, By End User

6.7.4 France Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.7.4.1 France Latent TB Testing Market, By Test Type

6.7.4.2 France Latent TB Testing Market, By End User

6.7.5 Rest of Europe Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.7.5.1 Rest of Europe Latent TB Testing Market, By Test Type

6.7.5.2 Rest of Europe Latent TB Testing Market, By End User



7. Asia Pacific Latent TB Testing Market: Historic and Forecast (2019-2029)

7.1 Asia Pacific Latent TB Testing Market: Snapshot

7.2 Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.3 Asia Pacific Latent TB Testing Market: Key Factors

7.4 Asia Pacific Latent TB Testing Market: Segment Analysis

7.5 Asia Pacific Latent TB Testing Market Segmentation: By Test Type

7.5.1 Asia Pacific Latent TB Testing Market, By Test Type Overview

7.5.2 Asia Pacific Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)

7.5.3 Asia Pacific Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)

7.6 Asia Pacific Latent TB Testing Market Segmentation: By End User

7.6.1 Asia Pacific Latent TB Testing Market, By End User Overview

7.6.2 Asia Pacific Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)

7.6.3 Asia Pacific Latent TB Testing Market Size, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)

7.6.4 Asia Pacific Latent TB Testing Market Size, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)

7.7 Asia Pacific Latent TB Testing Market Segmentation: By Country

7.7.1 Asia Pacific Latent TB Testing Market, By Country Overview

7.7.2 China Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.2.1 China Latent TB Testing Market, By Test Type

7.7.2.2 China Latent TB Testing Market, By End User

7.7.3 Japan Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.3.1 Japan Latent TB Testing Market, By Test Type

7.7.3.2 Japan Latent TB Testing Market, By End User

7.7.4 India Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.4.1 India Latent TB Testing Market, By Test Type

7.7.4.2 India Latent TB Testing Market, By End User

7.7.5 South Korea Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.5.1 South Korea Latent TB Testing Market, By Test Type

7.7.5.2 South Korea Latent TB Testing Market, By End User

7.7.6 Australia Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.6.1 Australia Latent TB Testing Market, By Test Type

7.7.6.2 Australia Latent TB Testing Market, By End User

7.7.7 Rest of Asia Pacific Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.7.7.1 Rest of Asia Pacific Latent TB Testing Market, By Test Type

7.7.7.2 Rest of Asia Pacific Latent TB Testing Market, By End User



8. Middle East and Africa Latent TB Testing Market: Historic and Forecast (2019-2029)

8.1 Middle East and Africa Latent TB Testing Market: Snapshot

8.2 Middle East and Africa Latent TB Testing Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

8.3 Middle East and Africa Latent TB Testing Market: Key Factors

8.4 Middle East and Africa Latent TB Testing Market: Segment Analysis

8.5 Middle East and Africa Latent TB Testing Market Segmentation: By Test Type

8.5.1 Middle East and Africa Latent TB Testing Market, By Test Type Overview

8.5.2 Middle East and Africa Latent TB Testing Market Size, By Tuberculin Skin Test (TST), By Value, 2019H-2029F (USD Million & CAGR)

8.5.3 Middle East and Africa Latent TB Testing Market Size, By Interferon Gamma Released Assay (IGRA), By Value, 2019H-2029F (USD Million & CAGR)

8.6 Middle East and Africa Latent TB Testing Market Segmentation: By End User

8.6.1 Middle East and Africa Latent TB Testing Market, By End User Overview

8.6.2 Middle East and Africa Latent TB Testing Market Size, By Diagnostic Laboratories, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East and Africa Latent TB Testing Market, By Hospitals and Clinics, By Value, 2019H-2029F (USD Million & CAGR)

8.6.4 Middle East and Africa Latent TB Testing Market, By Academic and Research Institute, By Value, 2019H-2029F (USD Million & CAGR)



9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Latent TB Testing Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Industry Ecosystem Analysis

10.1 Porter Analysis



11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Latent TB Testing Market

11.4 Company Profiling

11.4.1 QIAGEN

11.4.2 Sanofi

11.4.3 Abbott Laboratories

11.4.4 F. Hoffmann-La Roche AG

11.4.5 Bio-Rad Laboratories

11.4.6 BioMerieux

11.4.7 Becton Dickinson and Co

11.4.8 Serum Institute of India

11.4.9 PerkinElmer Inc.

11.4.10 LIONEX GmbH